Part1 How the Emergence of Innovative Biologic Agents Impacts Benefit Design, Utilization, and Provider Relations

Detalles Bibliográficos
Autores principales: Lipsy, Robert J., Mansukani, Sharad, Roski, Joachim, Fuller, Mark G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2004
Materias:
Cea
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437495/
https://www.ncbi.nlm.nih.gov/pubmed/15228370
http://dx.doi.org/10.18553/jmcp.2004.10.S3-a.S4
_version_ 1785092537637142528
author Lipsy, Robert J.
Mansukani, Sharad
Roski, Joachim
Fuller, Mark G.
author_facet Lipsy, Robert J.
Mansukani, Sharad
Roski, Joachim
Fuller, Mark G.
author_sort Lipsy, Robert J.
collection PubMed
description
format Online
Article
Text
id pubmed-10437495
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher Academy of Managed Care Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-104374952023-08-21 Part1 How the Emergence of Innovative Biologic Agents Impacts Benefit Design, Utilization, and Provider Relations Lipsy, Robert J. Mansukani, Sharad Roski, Joachim Fuller, Mark G. J Manag Care Pharm Cea Academy of Managed Care Pharmacy 2004-05 /pmc/articles/PMC10437495/ /pubmed/15228370 http://dx.doi.org/10.18553/jmcp.2004.10.S3-a.S4 Text en Copyright © 2004, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Cea
Lipsy, Robert J.
Mansukani, Sharad
Roski, Joachim
Fuller, Mark G.
Part1 How the Emergence of Innovative Biologic Agents Impacts Benefit Design, Utilization, and Provider Relations
title Part1 How the Emergence of Innovative Biologic Agents Impacts Benefit Design, Utilization, and Provider Relations
title_full Part1 How the Emergence of Innovative Biologic Agents Impacts Benefit Design, Utilization, and Provider Relations
title_fullStr Part1 How the Emergence of Innovative Biologic Agents Impacts Benefit Design, Utilization, and Provider Relations
title_full_unstemmed Part1 How the Emergence of Innovative Biologic Agents Impacts Benefit Design, Utilization, and Provider Relations
title_short Part1 How the Emergence of Innovative Biologic Agents Impacts Benefit Design, Utilization, and Provider Relations
title_sort part1 how the emergence of innovative biologic agents impacts benefit design, utilization, and provider relations
topic Cea
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437495/
https://www.ncbi.nlm.nih.gov/pubmed/15228370
http://dx.doi.org/10.18553/jmcp.2004.10.S3-a.S4
work_keys_str_mv AT lipsyrobertj part1howtheemergenceofinnovativebiologicagentsimpactsbenefitdesignutilizationandproviderrelations
AT mansukanisharad part1howtheemergenceofinnovativebiologicagentsimpactsbenefitdesignutilizationandproviderrelations
AT roskijoachim part1howtheemergenceofinnovativebiologicagentsimpactsbenefitdesignutilizationandproviderrelations
AT fullermarkg part1howtheemergenceofinnovativebiologicagentsimpactsbenefitdesignutilizationandproviderrelations

Ejemplares similares